Seminars in Hematology
Volume 43, Supplement 2 , Pages S44-S49, April 2006

Purine Analogue-Based Chemotherapy Regimens for Second-Line Therapy in Patients With Chronic Lymphocytic Leukemia

  • Nicole Lamanna
    • ,
  • Mark A. Weiss

      Affiliations

    • Corresponding Author InformationAddress correspondence to Mark A. Weiss, MD, Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021

Department of Medicine, Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0037-1963(05)00266-0

doi:10.1053/j.seminhematol.2005.12.009

Seminars in Hematology
Volume 43, Supplement 2 , Pages S44-S49, April 2006

Article Tools